Éric Piver

Maintenance of Remission Among Patients With Crohn's Disease on Antimetabolite Therapy After Infliximab Therapy Is Stopped

Édouard Louis, Jean‐Yves Mary, Gwénola Vernier-Massouille et al. · Gastroenterology · 2011 · 593 citations · Full text

Pharmacy, Immunology, Pharmacotherapy +14

Alterations in the Intestinal Microbiome (Dysbiosis) as a Predictor of Relapse After Infliximab Withdrawal in Crohnʼs Disease

Sylvie Rajca, Virginie Grondin, Édouard Louis et al. · Inflammatory Bowel Diseases · 2014 · 236 citations · Full text

Life Sciences, Immunology, Microbiology +17

The specific metabolome profiling of patients infected by SARS-COV-2 supports the key role of tryptophan-nicotinamide pathway and cytosine metabolism

Hélène Blasco, C. Bessy, Laurent Plantier et al. · Scientific Reports · 2020 · 150 citations · Full text

Life Sciences, Infectious Diseases, Molecular Medicine +17

Serum calprotectin as a biomarker for Crohn's disease

Marie‐Alice Meuwis, G. Vernier‐Massouille, J. C. Grimaud et al. · Journal of Crohn s and Colitis · 2013 · 138 citations

Medicine, Clinical Sciences, Internal Medicine +17

Highly efficient in vitro and in vivo delivery of functional RNAs using new versatile MS2-chimeric retrovirus-like particles

Anne Prel, Vincent Caval, Régis Gayon et al. · Molecular Therapy — Methods & Clinical Development · 2015 · 87 citations · Full text

Pharmacy, Biotechnology, Molecular Biology +17